Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/sage/preclinical-efficacy-of-african-medicinal-plants-used-in-the-treatment-gCYZi7igve
References (38)
-
( Félix-SilvaJ Silva-JuniorAA ZucolottoSM , et al. Medicinal plants for the treatment of local tissue damage induced by snake venoms: an overview from traditional use to pharmacological evidence. Evid Based Complement Alternat Med 2017; 2017: 5748256.28904556)
Félix-SilvaJ Silva-JuniorAA ZucolottoSM , et al. Medicinal plants for the treatment of local tissue damage induced by snake venoms: an overview from traditional use to pharmacological evidence. Evid Based Complement Alternat Med 2017; 2017: 5748256.28904556Félix-SilvaJ Silva-JuniorAA ZucolottoSM , et al. Medicinal plants for the treatment of local tissue damage induced by snake venoms: an overview from traditional use to pharmacological evidence. Evid Based Complement Alternat Med 2017; 2017: 5748256.28904556, Félix-SilvaJ Silva-JuniorAA ZucolottoSM , et al. Medicinal plants for the treatment of local tissue damage induced by snake venoms: an overview from traditional use to pharmacological evidence. Evid Based Complement Alternat Med 2017; 2017: 5748256.28904556
-
The World Health Organization. WHO traditional medicine strategy 'WHO traditional medicine strategy -
( World Health Organization (WHO). National policy on traditional medicine and regulation of herbal medicines. Report of WHO global survey, WHO, Geneva, February, 2019.)
World Health Organization (WHO). National policy on traditional medicine and regulation of herbal medicines. Report of WHO global survey, WHO, Geneva, February, 2019.World Health Organization (WHO). National policy on traditional medicine and regulation of herbal medicines. Report of WHO global survey, WHO, Geneva, February, 2019., World Health Organization (WHO). National policy on traditional medicine and regulation of herbal medicines. Report of WHO global survey, WHO, Geneva, February, 2019.
-
( AmeenSA SalihuT MbaojiCO , et al. Medicinal plants used to treat Snake bite by Fulani Herdsmen in Taraba State. Int J Appl Agric Apic Res 2015; 11: 10–21.)
AmeenSA SalihuT MbaojiCO , et al. Medicinal plants used to treat Snake bite by Fulani Herdsmen in Taraba State. Int J Appl Agric Apic Res 2015; 11: 10–21.AmeenSA SalihuT MbaojiCO , et al. Medicinal plants used to treat Snake bite by Fulani Herdsmen in Taraba State. Int J Appl Agric Apic Res 2015; 11: 10–21., AmeenSA SalihuT MbaojiCO , et al. Medicinal plants used to treat Snake bite by Fulani Herdsmen in Taraba State. Int J Appl Agric Apic Res 2015; 11: 10–21.
-
National policy on traditional medicine and regulation of herbal medicines -
( HabibAG BrownNI . The snakebite problem and antivenom crisis from a health-economic perspective. Toxicon 2018; 150: 115–123.29782952)
HabibAG BrownNI . The snakebite problem and antivenom crisis from a health-economic perspective. Toxicon 2018; 150: 115–123.29782952HabibAG BrownNI . The snakebite problem and antivenom crisis from a health-economic perspective. Toxicon 2018; 150: 115–123.29782952, HabibAG BrownNI . The snakebite problem and antivenom crisis from a health-economic perspective. Toxicon 2018; 150: 115–123.29782952
-
( AbubakarMS BalogunE AbdurahmanEM , et al. Ethnomedical treatment of poisonous snakebites: plant extract neutralized najanigricollis venom. Pharm Biol 2006; 44: 343–348.)
AbubakarMS BalogunE AbdurahmanEM , et al. Ethnomedical treatment of poisonous snakebites: plant extract neutralized najanigricollis venom. Pharm Biol 2006; 44: 343–348.AbubakarMS BalogunE AbdurahmanEM , et al. Ethnomedical treatment of poisonous snakebites: plant extract neutralized najanigricollis venom. Pharm Biol 2006; 44: 343–348., AbubakarMS BalogunE AbdurahmanEM , et al. Ethnomedical treatment of poisonous snakebites: plant extract neutralized najanigricollis venom. Pharm Biol 2006; 44: 343–348.
-
Juliana Félix-Silva, A. Silva-Júnior, S. Zucolotto, M. Fernandes-Pedrosa (2017)
Medicinal Plants for the Treatment of Local Tissue Damage Induced by Snake Venoms: An Overview from Traditional Use to Pharmacological EvidenceEvidence-based Complementary and Alternative Medicine : eCAM, 2017
-
(1954)
THE WORLD HEALTH ORGANIZATIONMedical Journal of Australia, 2
-
M. Alam, A. Gomes (2003)
Snake venom neutralization by Indian medicinal plants (Vitex negundo and Emblica officinalis) root extracts.Journal of ethnopharmacology, 86 1
-
Collaborative approach to meta-analysis and review of animal data from experimental studies -
M. Abubakar, E. Balogun, E. Abdurahman, A. Nok, M. Shok, A. Mohammed, M. Garba (2006)
Ethnomedical Treatment of Poisonous Snakebites: Plant Extract Neutralized Naja nigricollis. VenomPharmaceutical Biology, 44
-
( GomesA DasR SarkhelS , et al. Herbs and herbal constituents active against snakebite. Indian J Exper Biol 2010; 9: 865–878.)
GomesA DasR SarkhelS , et al. Herbs and herbal constituents active against snakebite. Indian J Exper Biol 2010; 9: 865–878.GomesA DasR SarkhelS , et al. Herbs and herbal constituents active against snakebite. Indian J Exper Biol 2010; 9: 865–878., GomesA DasR SarkhelS , et al. Herbs and herbal constituents active against snakebite. Indian J Exper Biol 2010; 9: 865–878.
-
( MorsWB Celia do NascimentoM Ruppelt PereiraBM , et al. Plant products active against snake bite – the molecular approach. Phytochemistry 2000; 55: 627–642.11130675)
MorsWB Celia do NascimentoM Ruppelt PereiraBM , et al. Plant products active against snake bite – the molecular approach. Phytochemistry 2000; 55: 627–642.11130675MorsWB Celia do NascimentoM Ruppelt PereiraBM , et al. Plant products active against snake bite – the molecular approach. Phytochemistry 2000; 55: 627–642.11130675, MorsWB Celia do NascimentoM Ruppelt PereiraBM , et al. Plant products active against snake bite – the molecular approach. Phytochemistry 2000; 55: 627–642.11130675
-
( Collaborative approach to meta-analysis and review of animal data from experimental studies (CAMARADES), http://www.camarades.info/index_files/Why%20CAMARADES.htm (2020, accessed May, 2021))
Collaborative approach to meta-analysis and review of animal data from experimental studies (CAMARADES), http://www.camarades.info/index_files/Why%20CAMARADES.htm (2020, accessed May, 2021)Collaborative approach to meta-analysis and review of animal data from experimental studies (CAMARADES), http://www.camarades.info/index_files/Why%20CAMARADES.htm (2020, accessed May, 2021), Collaborative approach to meta-analysis and review of animal data from experimental studies (CAMARADES), http://www.camarades.info/index_files/Why%20CAMARADES.htm (2020, accessed May, 2021)
-
T. Amom, Shimbe Yahwe, Anyam, John Vershima (2013)
Phytochemical and Medicinal activities of Hymenocardia acida Tul(Euphorbiaceae): A ReviewJournal of Natural Product and Plant Resources, 3
-
(1995)
In vivo antisnake venom acivity of the furoid diterpene from Aristolochia albida Duch -
M. Abubakar, M. Sule, U. Pateh, E. Abdurahman, A. Haruna, B. Jahun (2000)
In vitro snake venom detoxifying action of the leaf extract of Guiera senegalensis.Journal of ethnopharmacology, 69 3
-
( World health organization (WHO). Annex 5. Guidelines for the production, control and regulation of snake antivenom immunoglobulins replacement of Annex 2 of WHO Technical Report Series, No. 964. WHO Technical Report Series 2017; 96: 197–388, https://www.who.int/bloodproducts/AntivenomGLrevWHO_TRS_1004_web_Annex_5.pdf)
World health organization (WHO). Annex 5. Guidelines for the production, control and regulation of snake antivenom immunoglobulins replacement of Annex 2 of WHO Technical Report Series, No. 964. WHO Technical Report Series 2017; 96: 197–388, https://www.who.int/bloodproducts/AntivenomGLrevWHO_TRS_1004_web_Annex_5.pdfWorld health organization (WHO). Annex 5. Guidelines for the production, control and regulation of snake antivenom immunoglobulins replacement of Annex 2 of WHO Technical Report Series, No. 964. WHO Technical Report Series 2017; 96: 197–388, https://www.who.int/bloodproducts/AntivenomGLrevWHO_TRS_1004_web_Annex_5.pdf, World health organization (WHO). Annex 5. Guidelines for the production, control and regulation of snake antivenom immunoglobulins replacement of Annex 2 of WHO Technical Report Series, No. 964. WHO Technical Report Series 2017; 96: 197–388, https://www.who.int/bloodproducts/AntivenomGLrevWHO_TRS_1004_web_Annex_5.pdf
-
( YusufPO MammanM AjagunE , et al. Snakes responsible for bites in Norths-Eastern Nigeria – a hospital based survey. IOSR J Envmlt Sci 2015; 9: 2319–2399.)
YusufPO MammanM AjagunE , et al. Snakes responsible for bites in Norths-Eastern Nigeria – a hospital based survey. IOSR J Envmlt Sci 2015; 9: 2319–2399.YusufPO MammanM AjagunE , et al. Snakes responsible for bites in Norths-Eastern Nigeria – a hospital based survey. IOSR J Envmlt Sci 2015; 9: 2319–2399., YusufPO MammanM AjagunE , et al. Snakes responsible for bites in Norths-Eastern Nigeria – a hospital based survey. IOSR J Envmlt Sci 2015; 9: 2319–2399.
-
A. Bala, A. Jatau, Ismaeel Yunusa, M. Mohammed, Al-Kassim Mohammed, A. Isa, Wada Sadiq, K. Gulma, Inuwa Bello, S. Malami, G. Michael, B. Chedi (2020)
Development and validation of antisnake venom knowledge assessment tool (AKAT) for healthcare practitionersToxicon: X, 8
-
( The World Health Organization. WHO traditional medicine strategy ‘WHO traditional medicine strategy: 2014-2023’, https://www.who.int/home/cms-decommissioning (2013 accessed May, 2021).)
The World Health Organization. WHO traditional medicine strategy ‘WHO traditional medicine strategy: 2014-2023’, https://www.who.int/home/cms-decommissioning (2013 accessed May, 2021).The World Health Organization. WHO traditional medicine strategy ‘WHO traditional medicine strategy: 2014-2023’, https://www.who.int/home/cms-decommissioning (2013 accessed May, 2021)., The World Health Organization. WHO traditional medicine strategy ‘WHO traditional medicine strategy: 2014-2023’, https://www.who.int/home/cms-decommissioning (2013 accessed May, 2021).
-
A. Habib, N. Brown (2018)
The snakebite problem and antivenom crisis from a health‐economic perspectiveToxicon, 150
-
( HunnifordVT MontroyJ FergussonDA , et al. Epidemiology and reporting characteristics of preclinical systematic reviews. PLoS Biol 2021; 9: e3001177.)
HunnifordVT MontroyJ FergussonDA , et al. Epidemiology and reporting characteristics of preclinical systematic reviews. PLoS Biol 2021; 9: e3001177.HunnifordVT MontroyJ FergussonDA , et al. Epidemiology and reporting characteristics of preclinical systematic reviews. PLoS Biol 2021; 9: e3001177., HunnifordVT MontroyJ FergussonDA , et al. Epidemiology and reporting characteristics of preclinical systematic reviews. PLoS Biol 2021; 9: e3001177.
-
( HooijmansCR RoversMM de VriesRB , et al. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol 2014; 26: 14–43.)
HooijmansCR RoversMM de VriesRB , et al. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol 2014; 26: 14–43.HooijmansCR RoversMM de VriesRB , et al. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol 2014; 26: 14–43., HooijmansCR RoversMM de VriesRB , et al. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol 2014; 26: 14–43.
-
( AlamMI GomesA . Snake venom neutralization by Indian medicinal plants (Vitex negundo and Emblica officinalis) root extracts. J Ethnopharmacol 2003; 86: 75–80.12686445)
AlamMI GomesA . Snake venom neutralization by Indian medicinal plants (Vitex negundo and Emblica officinalis) root extracts. J Ethnopharmacol 2003; 86: 75–80.12686445AlamMI GomesA . Snake venom neutralization by Indian medicinal plants (Vitex negundo and Emblica officinalis) root extracts. J Ethnopharmacol 2003; 86: 75–80.12686445, AlamMI GomesA . Snake venom neutralization by Indian medicinal plants (Vitex negundo and Emblica officinalis) root extracts. J Ethnopharmacol 2003; 86: 75–80.12686445
-
( BalaAA JatauAI YunusaI , et al. Development and validation of antisnake venom knowledge assessment tool (AKAT) for healthcare practitioners. Toxicon: X 2020; 8: 2590–1710.)
BalaAA JatauAI YunusaI , et al. Development and validation of antisnake venom knowledge assessment tool (AKAT) for healthcare practitioners. Toxicon: X 2020; 8: 2590–1710.BalaAA JatauAI YunusaI , et al. Development and validation of antisnake venom knowledge assessment tool (AKAT) for healthcare practitioners. Toxicon: X 2020; 8: 2590–1710., BalaAA JatauAI YunusaI , et al. Development and validation of antisnake venom knowledge assessment tool (AKAT) for healthcare practitioners. Toxicon: X 2020; 8: 2590–1710.
-
(2015)
Snakes responsible for bites in Norths-Eastern Nigeria – a hospital based survey -
Victoria Hunniford, J. Montroy, D. Fergusson, M. Avey, K. Wever, S. McCann, Madison Foster, Grace Fox, Mackenzie Lafreniere, M. Ghaly, Sydney Mannell, Karolina Godwinska, Avonae Gentles, Shehab Selim, Jenna MacNeil, L. Sikora, E. Sena, M. Page, M. Macleod, D. Moher, M. Lalu (2021)
Epidemiology and reporting characteristics of preclinical systematic reviewsPLoS Biology, 19
-
( HarunaAK ChoudhuryMK . In vivo antisnake venom acivity of the furoid diterpene from Aristolochia albida Duch. Indian J Pharm Sci 1995; 27: 222–224.)
HarunaAK ChoudhuryMK . In vivo antisnake venom acivity of the furoid diterpene from Aristolochia albida Duch. Indian J Pharm Sci 1995; 27: 222–224.HarunaAK ChoudhuryMK . In vivo antisnake venom acivity of the furoid diterpene from Aristolochia albida Duch. Indian J Pharm Sci 1995; 27: 222–224., HarunaAK ChoudhuryMK . In vivo antisnake venom acivity of the furoid diterpene from Aristolochia albida Duch. Indian J Pharm Sci 1995; 27: 222–224.
-
A. Gomes, R. Das, S. Sarkhel, Roshnara Mishra, S. Mukherjee, Shamik Bhattacharya, A. Gomes (2010)
Herbs and herbal constituents active against snake bite.Indian journal of experimental biology, 48 9
-
(2000)
Plant products active against snake bite – the molecular approach -
( RooneyA . Extending a risk of bias approach to address in vitro studies. extending a risk-of-bias approach to address in vitro studies, https://ofmpub.epa.gov/eims/eimscomm.getfile?p_download_id=526750 (2015, accessed May, 2021).)
RooneyA . Extending a risk of bias approach to address in vitro studies. extending a risk-of-bias approach to address in vitro studies, https://ofmpub.epa.gov/eims/eimscomm.getfile?p_download_id=526750 (2015, accessed May, 2021).RooneyA . Extending a risk of bias approach to address in vitro studies. extending a risk-of-bias approach to address in vitro studies, https://ofmpub.epa.gov/eims/eimscomm.getfile?p_download_id=526750 (2015, accessed May, 2021)., RooneyA . Extending a risk of bias approach to address in vitro studies. extending a risk-of-bias approach to address in vitro studies, https://ofmpub.epa.gov/eims/eimscomm.getfile?p_download_id=526750 (2015, accessed May, 2021).
-
C. Hooijmans, M. Rovers, R. Vries, M. Leenaars, M. Ritskes-Hoitinga, M. Langendam (2014)
SYRCLE’s risk of bias tool for animal studiesBMC Medical Research Methodology, 14
-
(2017)
Annex 5. Guidelines for the production, control and regulation of snake antivenom immunoglobulins replacement of Annex 2 of WHO -
(2015)
Medicinal plants used to treat Snake bite by Fulani Herdsmen in Taraba State -
(2021)
Extending a risk of bias approach to address in vitro studies. extending a risk-of-bias approach to address in vitro studies, https:// ofmpub.epa.gov/eims/eimscomm.getfile?p_ download_id=526750 (2015 -
( Tor-AnyiinTA ShimbeRY AnyamJV . Phytochemical and medicinalactivities of Hymenocardia acida Tul (Euphorbiaceae): a review. J Natl Prod Plant Res 2013; 4: 11–16.)
Tor-AnyiinTA ShimbeRY AnyamJV . Phytochemical and medicinalactivities of Hymenocardia acida Tul (Euphorbiaceae): a review. J Natl Prod Plant Res 2013; 4: 11–16.Tor-AnyiinTA ShimbeRY AnyamJV . Phytochemical and medicinalactivities of Hymenocardia acida Tul (Euphorbiaceae): a review. J Natl Prod Plant Res 2013; 4: 11–16., Tor-AnyiinTA ShimbeRY AnyamJV . Phytochemical and medicinalactivities of Hymenocardia acida Tul (Euphorbiaceae): a review. J Natl Prod Plant Res 2013; 4: 11–16.
- Publisher
- SAGE
- Copyright
- © The Author(s), 2022
- ISSN
- 2049-9361
- eISSN
- 2049-937X
- DOI
- 10.1177/20499361211072644
- Publisher site
- See Article on Publisher Site
Abstract
Background:Snakebite envenoming (SBE) is a high-priority, neglected, tropical disease that affects millions of people in developing countries annually. The only available standard drug used for the treatment of SBE is antisnake venom (ASV) which consists of immunoglobulins that have been purified from the plasma of animals hyper-immunized against snake venoms. The use of plants as alternatives for treatment of poisonous bites particularly snakebites is important in remote areas where there might be limited, or no access to hospitals and storage facilities for antivenom. The pharmacological activity of some of the medicinal plants used traditionally in the treatment of SBE have also been scientifically validated.Method:A systematic review will be conducted according to the Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies checklist for study quality in animal/in vivo studies. The tool will be modified and validated to assess in vitro models and studies that combine in vivo and in vitro studies. The systematic review will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. English published articles on African medicinal plants used in the treatment of snakebite envenoming will be searched in Medline, Embase, and Scopus from 2000 to 2021.Dissemination:The findings of the study will be communicated through publication in peer-reviewed journal and presentation at scientific conferences. Medicinal plants have been important sources for the development of many effective drugs currently available in orthodox medicine. Botanically derived medicines have played a major role in human societies throughout history. Plants components used in traditional medicine gained much attention by many toxinologists as a tool for designing potent antidotes against snake envenoming. Our systematic review will provide a synthesis of the literature on the efficacy of these medicinal plants. We will also appraise the prospects of African medicinal plants with pharmacologically demonstrated activity against snakebite and envenoming.
Journal
Therapeutic Advances in Infectious Disease – SAGE
Published: Feb 1, 2022